Diagnos Laboratorium Utama Tbk. vs Japfa Comfeed Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 77.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (8.44M versus 129.6K). Which is the better fit depends on your goals.
| DGNS | JPFA | |
|---|---|---|
Market Cap | 308B | 23.8T |
Volume | 129.6K | 8.44M |
Lot | 1.3K | 84.36K |
Turnover | 28.71M | 17.08B |
Average Price | 221.54 | 2,024.41 |
Value | 28.71M | 17.08B |
Indicative Equilibrium Price | 230 | 2,030 |
Indicative Equilibrium Volume | 110 | 3.58K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →